Skip to content

Bioenergy, Depression, Anxiety and Stress After Liver Transplantation

The Effect of Bioenergy Application

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06297018
Enrollment
140
Registered
2024-03-06
Start date
2024-01-01
Completion date
2024-02-09
Last updated
2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental Health Issue

Keywords

Biyoenergy, anxiety, stress, liver transplant recipients

Brief summary

In this study, the investigators aimed to examine the effect of bioenergy application on depression, anxiety and stress after liver transplantation.

Detailed description

Simple random sampling method was used to assign liver recipients to experimental and control groups. Discharged liver transplant patients will be investigated for anxiety, stress and depression.

Interventions

BEHAVIORALBioenergy application

Bioenergy application: This group includes liver transplant recipients and recipients who underwent intervention. Depression, anxiety and stress levels are measured in the pre-test. Bioenergy is then applied. As a post-test, depression, anxiety and stress levels are measured again.

Sponsors

Istanbul Aydın University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

Experimental

Intervention model description

Interventional Crossover Assignment

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

(i) liver transplant recipient (ii) must be able to use immunosuppressive agents (iii) 18 years or older Liver transplant recipients

Exclusion criteria

having psychiatric problems having language and communication problems

Design outcomes

Primary

MeasureTime frameDescription
Anxiety, stress, depression: Measurement will be made with the Depression Anxiety Stress 21 Scale (DASS-21: Score range 21-63)total of six monthIt will be measure Therapy on Liver Transplant Recipients'

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026